Procter & Gamble Stocks Decrease 2.62% as $1.4 Billion Cost Burden Grows

Procter & Gamble (PG) reported a strong fiscal first quarter with 4% organic sales growth and $23.3B in revenue, exceeding estimates. EPS rose to $2.00, topping consensus. Despite higher commodity costs, the company maintained full-year EPS guidance. The stock surged 5.6% on the news, its best day in over six years, highlighting resilience in consumer demand despite inflation.

Procter & Gamble (PG) shares fell 2.62% to $161.25 as it raised its fiscal 2027 commodity-cost forecast to $1.4B. Q3 organic sales grew 4%, but core earnings rose just 1% to $2/share. Margins contracted 80 bps despite productivity gains. Revenue hit $23.3B. Management kept its annual guidance.

Procter & Gamble (P&G) saw its best trading day since March 2020, adding $20B in market value. Investors favored its reliable consumer staples amid market uncertainty, driving a 4% sales increase in Q1. P&G shares reached their highest close since February, trading at 22 times expected earnings. Other consumer staples like Kimberly-Clark and Colgate-Palmolive also gained, supported by falling interest rates.

Procter & Gamble (P&G) reported Q1 adjusted earnings of $2.00 per share, beating estimates, with revenue of $23.28 billion also topping forecasts. The company maintained its fiscal 2027 organic sales and EPS growth outlooks but raised its all-in sales growth outlook to 2%-4% due to its acquisition of Thorne. P&G also increased its estimated fiscal 2027 after-tax commodity cost headwind to $1.4 billion.

TD Cowen raised its price target for Procter & Gamble (NYSE:PG) to $166 from $150, citing strong Q1 performance and potential for full-year guidance. The firm maintained a Hold rating due to uncertainty about U.S. momentum. PG reported Q1 earnings of $2.00 per share on $23.28B revenue, exceeding estimates. Morgan Stanley also raised its target to $185, highlighting profit upside.

Procter & Gamble (PG) reported Q1 fiscal 2027 earnings of $2.00 per share, beating estimates, with revenues up 4% to $23.28 billion. Management highlighted organic growth but cautioned about rising commodity costs. PG maintained its full-year outlook, expecting 1-3% organic sales growth and 0-3% core earnings growth. Higher costs are pressuring margins, with a projected $1.9 billion after-tax headwind.